DATABASE

ABCDEFGHIJKLMNOPQRSTUVWXYZ


Name Category
Actelion delivers strong first quarter 2013 results News
Actelion erhält Zulassung für Epoprostenol "ACT" in Japan News
Actelion Ltd. Fund
Actelion mit starken Ergebnissen im ersten Quartal 2013 News
Actelion nominiert John J. Greisch zur Wahl in den Verwaltungsrat News
Actelion obtains marketing approval for Epoprostenol "ACT" in Japan News
Actelion Pharmaceuticals Russia Deploys Cloud-Based Mobile Intelligence™ to Leverage CRM Innovation in Pivotal Emerging Market News
Actelion präsentiert anlässlich der 31. J.P. Morgan Healthcare Conference - Umsetzung der Strategie von Actelion News
Actelion reicht Zulassungsantrag für Macitentan (Opsumit) bei der Europäischen Arzneimittel-Agentur (EMA) ein News
Actelion submits the registration dossier for macitentan (Opsumit) to the European Medicines Agency (EMA) News
Actelion to discuss nine months 2012 financial results News
Actelion to present at the 31st Annual J.P. Morgan Healthcare Conference - Delivering on our strategy News
Actelion's Annual General Meeting of Shareholders held in Basel, Switzerland News
Actelion's novel antibiotic cadazolid to move into Phase III clinical development in patients suffering from Clostridium difficile associated diarrhea News
Actelion's ponesimod successful in mid-stage trial in patients with moderate to severe chronic plaque psoriasis - Ponesimod to proceed to Phase III cl News
Actelions neuartiges Antibiotikum Cadazolid geht in Phase III der klinischen Entwicklung bei Patienten, die an Clostridium-difficile-assoziierter Diar News
Actelions Ponesimod erfolgreich in fortgeschrittener Studie bei Patienten mit mittelschwerer bis schwerer Plaque-Psoriasis - Ponesimod geht in die Pha News
Acteos Fund
Acti-bail Bank
Actielec Technologies Fund
Actieninvest AG Company
Actigep Bank
Actinogen Limited Fund
Actinver Casa De Bolsa Sa De Cv Bank
Actinvest Sa Bank
Page 130 of 1100